[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100393996":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":66,"collaborators":68,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":10,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":10,"studyType":85,"phases":10,"briefSummary":86,"conditions":87,"keywords":10,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"University of California, Davis","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ancillary-correlative (biospecimen collection)",null,"Patients undergo collection of tumor tissue samples during standard of care tumor biopsy or surgical resection to establish PDXs. Patients may also undergo collection of blood, saliva, and urine samples to compare DNA abnormalities to noncancer cells in order to determine if they were present before the cancer started or developed with it.",[13],"Procedure: Biospecimen Collection",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Biospecimen Collection","Undergo collection of tumor tissue, blood, saliva, and urine samples",[9],[21],{"name":22,"affiliation":5,"role":23},"Luis G Carvajal-Carmona","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Asst. Clinical Research Coordinator","CONTACT","916-734-1587","tfle@ucdavis.edu",[31,51],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"UC Irvine Health\u002FChao Family Comprehensive Cancer Center","RECRUITING","Orange","California","92868","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-117.85311,33.78779,{"lat":43,"lon":42},[46,50],{"name":47,"role":27,"phone":48,"phoneExt":10,"email":49},"Marian Waterman","949-824-2885","marian.waterman@uci.edu",{"name":47,"role":23,"phone":10,"phoneExt":10,"email":10},{"facility":52,"status":33,"city":53,"state":35,"zip":54,"country":37,"countryCode":38,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"University of California Davis Comprehensive Cancer Center","Sacramento","95817",{"type":40,"coordinates":56},[57,58],-121.4944,38.58157,{"lat":58,"lon":57},[61,65],{"name":62,"role":27,"phone":63,"phoneExt":10,"email":64},"Luis G. Carvajal-Carmona","530-752-9654","lgcarvajal@ucdavis.edu",{"name":62,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":67,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[69],{"name":70,"class":71},"National Cancer Institute (NCI)","NIH","100393996","patient-derived-xenografts-to-reduce-cancer-health-disparities-100393996",false,"NCT04410302","Patient-Derived Xenografts to Reduce Cancer Health Disparities","University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities","Inclusion Criteria:\n\n* Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric\u002Fstomach cancer, and liver cancer)\n* Signed informed consent that will be put on file\n\nExclusion Criteria:\n\n* No informed consent obtained\n* Specimen unacceptable\u002Fdegraded\u002Fetc.\n* Individuals who are not yet adults (infants, children, teenagers)\n* Pregnant women\n* Prisoners\n* Adults unable to consent","ALL","21 Years","100 Years",{"count":83,"type":84},500,"ESTIMATED","OBSERVATIONAL","This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial\u002Fethnic minorities. Understanding the genetic and response differences among racial\u002Fethnic minorities may help researchers enhance the precision of therapeutic treatments.",[88,89,90,91,92],"Bladder Carcinoma","Gastric Carcinoma","Liver and Intrahepatic Bile Duct Carcinoma","Lung Carcinoma","Malignant Neoplasm","2026-08-18",{"date":95,"type":96},"2026-08-20","ACTUAL",{"date":98,"type":96},"2019-11-12",{"date":100,"type":84},"2027-06",{"name":5,"class":6},2]